Valneva SE ADR (VALN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $10.91
• Market Cap: $991.26M
• EPS: $-1.53
• 52-Week High: $12.25
• 52-Week Low: $5.43

Market Sentiment

Valneva SE ADR currently has a Bullish sentiment score of 0.38.

About Valneva SE ADR

Valneva SE ADR is a biotechnology company based in Saint-Herblain, France, specializing in the development and commercialization of innovative vaccines targeting infectious diseases with considerable unmet medical needs. The company's robust pipeline includes vaccine candidates for Lyme disease and chikungunya, exemplifying its commitment to addressing critical health challenges through advanced research and technology. With a strategic focus on unique and effective vaccine solutions, Valneva...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Valneva SE ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VALN pay dividends?

Valneva SE ADR (VALN) does not currently pay a regular dividend.

What is VALN's market cap?

Valneva SE ADR (VALN) has a market capitalization of $991.26M with a current stock price of $10.91.